Area of research
Immunology · Oncology
Research interest
Research interests include Immune Cell Function and Interaction, Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, and CAR-T cell therapy research.
Functional differences between rodent and human PD-1 linked to evolutionary divergence
Functional differences between rodent and human PD-1 linked to evolutionary divergence.
RGI-2001 for the prophylaxis of acute graft-versus-host disease after allogeneic HCT.
MAP kinase kinase 1 (MEK1) within extracellular vesicles inhibits tumour growth by promoting anti-tumour immunity.
cis-B7:CD28 interactions at invaginated synaptic membranes provide CD28 co-stimulation and promote CD8+ T cell function and anti-tumor immunity
CTLA4 depletes T cell endogenous and trogocytosed B7 ligands via cis-endocytosis
CTLA4 depletes T cell endogenous and trogocytosed B7 ligands via cis-endocytosis.
A cell-level discriminative neural network model for diagnosis of blood cancers
Dual receptor T cells mediate effective antitumor immune responses via increased recognition of tumor antigens.
Supplementary Data from AMC-070: Lenalidomide Is Safe and Effective in HIV-Associated Kaposi Sarcoma
Supplementary Data from AMC-070: Lenalidomide Is Safe and Effective in HIV-Associated Kaposi Sarcoma
Data from AMC-070: Lenalidomide Is Safe and Effective in HIV-Associated Kaposi Sarcoma
Data from AMC-070: Lenalidomide Is Safe and Effective in HIV-Associated Kaposi Sarcoma
Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCC
Cancer-cell-secreted extracellular vesicles suppress insulin secretion through miR-122 to impair systemic glucose homeostasis and contribute to tumour growth
Monomethyl auristatin antibody and peptide drug conjugates for trimodal cancer chemo-radio-immunotherapy
AMC-070: Lenalidomide Is Safe and Effective in HIV-Associated Kaposi Sarcoma
Lymphatic-Preserving Treatment Sequencing with Immune Checkpoint Inhibition Unleashes cDC1-Dependent Antitumor Immunity in HNSCC
Intratumoral immunotherapy using platelet-cloaked nanoparticles enhances antitumor immunity in solid tumors
Genetically engineered and enucleated human mesenchymal stromal cells for the targeted delivery of therapeutics to diseased tissue
Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers
Heterogeneity and clonal relationships of adaptive immune cells in ulcerative colitis revealed by single-cell analyses
Heterogeneity and clonal relationships of adaptive immune cells in ulcerative colitis revealed by single-cell analyses.
Elongated neutrophil-derived structures are blood-borne microparticles formed by rolling neutrophils during sepsis
Elongated neutrophil-derived structures are blood-borne microparticles formed by rolling neutrophils during sepsis
Evaluation of IL-17D in Host Immunity to Group A <i>Streptococcus</i> Infection.
PD-L1:CD80 Cis-Heterodimer Triggers the Co-stimulatory Receptor CD28 While Repressing the Inhibitory PD-1 and CTLA-4 Pathways
Safety and efficacy of AMG 714 in patients with type 2 refractory coeliac disease: a phase 2a, randomised, double-blind, placebo-controlled, parallel-group study
Immuno-oncological Efficacy of RXDX-106, a Novel TAM (TYRO3, AXL, MER) Family Small-Molecule Kinase Inhibitor
Survival of syngeneic and allogeneic iPSC–derived neural precursors after spinal grafting in minipigs